ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 76 filers reported holding ASTRIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,598,717 | -8.5% | 1,688,836 | +2.2% | 0.00% | – |
| Q2 2023 | $13,765,407 | +258.9% | 1,652,510 | +473.1% | 0.00% | – |
| Q1 2023 | $3,835,308 | +181.2% | 288,369 | +214.8% | 0.00% | – |
| Q4 2022 | $1,363,909 | +92.6% | 91,599 | +16.9% | 0.00% | – |
| Q3 2022 | $708,000 | +282.7% | 78,325 | +27.4% | 0.00% | – |
| Q2 2022 | $185,000 | -45.3% | 61,457 | +22.0% | 0.00% | – |
| Q1 2022 | $338,000 | +17.8% | 50,386 | -5.1% | 0.00% | – |
| Q4 2021 | $287,000 | -20.9% | 53,073 | +29.1% | 0.00% | – |
| Q3 2021 | $363,000 | – | 41,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 911,736 | $8,060,000 | 2.93% |
| VR Adviser, LLC | 538,999 | $4,765,000 | 0.61% |
| COMMODORE CAPITAL LP | 239,270 | $2,115,000 | 0.56% |
| Perceptive Advisors | 1,959,652 | $17,323,000 | 0.25% |
| Cormorant Asset Management, LP | 552,903 | $4,888,000 | 0.20% |
| RA Capital Management | 1,262,193 | $11,158,000 | 0.16% |
| Soleus Capital Management, L.P. | 112,499 | $994,000 | 0.16% |
| ArchPoint Investors | 28,247 | $250,000 | 0.08% |
| Ikarian Capital, LLC | 87,580 | $775,000 | 0.06% |
| Old Well Partners, LLC | 12,116 | $107,000 | 0.06% |